中国寄生虫学与寄生虫病杂志 ›› 2006, Vol. 24 ›› Issue (2): 5-105.

• 论著 • 上一篇    下一篇

恶性疟原虫对咯萘啶敏感性的体外微量测试方法

刘德全;冯晓平;刘瑞君;张春勇   

  1. 中国疾病预防控制中心寄生虫病预防控制所, 世界卫生组织疟疾、血吸虫病和丝虫病合作中心, 上海 200025
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2006-04-30 发布日期:2006-04-30

Establishment of In vitro Microtest for Determining Sensitivity ofPlasmodium falciparum to Pyronaridine

LIU De-quan;FENG Xiao-ping;LIU Rui-jun;ZHANG Chun-yong   

  1. National Institute of Parasitic Diseases, Chinese Centre for Disease Control and Prevention, WHOCollaboration Centre for Malaria, Schistosomiasis and Filariasis, Shanghai 200025, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2006-04-30 Published:2006-04-30

摘要: 目的 研究并建立恶性疟原虫对咯萘啶敏感性的体外微量测试方法。 方法 研制咯萘啶涂药板和便于现场使用的培养基,先在实验室用体外连续培养的恶性疟原虫(FCC1/HN)测试,证明咯萘啶涂药板和培养基的效果稳定可靠后,在疟疾流行高峰季节赴海南省及云南省现场,取恶性疟现症病人血样,测试恶性疟原虫对咯萘啶的敏感性,并设体内四周法为对照。 结果 研制的咯萘啶涂药板及现场用的培养基效果稳定,咯萘啶涂药板4 ℃贮存有效期为6个月,4 ℃贮存的安瓿封装液体培养基及瓶装冰冻干燥培养基有效期分别为2个月和2年。经过多年现场测试,不但掌握了我国恶性疟原虫对咯萘啶敏感性的基线数据,同时还显示,在目前咯萘啶临床治疗效果仍较满意的情况下,恶性疟原虫对咯萘啶的敏感性已在逐渐降低,而且体外完全抑制裂殖体形成的平均药浓度提高了2~4倍。 结论 恶性疟原虫对咯萘啶的敏感性可用体外微量法测试,较体内四周法更为方便和敏感。

关键词: 恶性疟原虫, 咯萘啶, 敏感性, 体外微量测试法

Abstract: Objective To establish an in vitro microtest for determining the sensitivity of Plasmodium falciparum to pyronaridine Methods Pyronaridine-coated plate and culture medium which is easy to use in the field were prepared. P.falciparum parasites from in vitro continuous passage culture(FCC1/HN) were used for experimental tests in the laboratory. When they were proved stable and reliable through repeated determinations, field trials were made in Hainan and Yunnan Provinces during the malaria transmission season with blood samples from clinical falciparum malaria cases. A 4-week in vivo test was carried out as a control. Results The pyronaridine-coated plate and culture medium were proved to be stable. The effective period of pyronaridine-coated plate, the ampule sealed liquid culture medium and the bottled lyophilized culture medium, all stored at 4 ℃ was 6 months, 2 months and 2 years respectively. Through several years field determinations, the baseline data of pyronaridine-sensitivity of P.falciparum in the country were collected and the sensitivity of P.falciparum to pyronaridine was also revealed to have decreased gradually. The mean drug concentration for in vitro complete inhibition of schizont formation raised by 2-4 times although the clinical therapeutic efficacy of pyronaridine was still satisfactory at the present time. Conclusion The developed in vitro microtest can be used for determination of the sensitivity of P.falciparum to pyronaridine, and it is more convenient and sensitive than the 4-week in vivo method.

Key words: Plasmodium falciparum, Pyronaridine, Sensitivity, In vitro microtest